Gene · 489
Papers2,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The sodium-glucose cotransporter 2 inhibitor tofogliflozin induces vasodilation of rabbit femoral artery by activating Kv channels, the SERCA pump, and the sGC/cGMP pathway. | Eur J Pharmacol | 2025 | 40189081 | PubTator, text mining | PubMed |
| CBP/CREB Regulates the Proliferation and Apoptosis of Cardiomyocytes by Interacting With SERCA. | J Cell Mol Med | 2025 | 39969158 | PubTator, text mining | PubMed |
| To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma. | Sci Rep | 2025 | 39920250 | PubTator, text mining | PubMed |
| The Protective Effect of Nimodipine in Schwann Cells Is Related to the Upregulation of LMO4 and SERCA3 Accompanied by the Fine-Tuning of Intracellular Calcium Levels. | Int J Mol Sci | 2025 | 39859578 | PubTator, text mining | PubMed |
| SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established. | Heart Fail Rev | 2025 | 39843817 | PubTator, text mining | PubMed |
| Mutational analysis of an antimalarial drug target, PfATP4. | Proc Natl Acad Sci U S A | 2025 | 39773028 | PubTator, text mining | PubMed |
| Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium. | J Biol Chem | 2025 | 39710323 | PubTator, text mining | PubMed |
| ATP2A3 in Primary Aldosteronism: Machine Learning-Based Discovery and Functional Validation. | Hypertension | 2025 | 39618394 | PubTator, text mining | PubMed |
| Vasorelaxant mechanisms of the antidiabetic anagliptin in rabbit aorta: roles of Kv channels and SERCA pump. | Acta Diabetol | 2025 | 39103505 | PubTator, text mining | PubMed |
| Identification and validation of a novel nine-gene prognostic signature of stem cell characteristic in hepatocellular carcinoma. | J Appl Genet | 2025 | 38441798 | PubTator, text mining | PubMed |
| Cynaropicrin Increases [Ca2+]i and Ciliary Beat Frequency in Human Airway Epithelial Cells by Inhibiting SERCA. | Biol Pharm Bull | 2024 | 39710380 | PubTator, text mining | PubMed |
| G-protein-coupled receptor 41 in cardiomyocytes: Effect of butyrate on intracellular Ca2+ and sarcomere shortening. | FASEB J | 2024 | 39652079 | PubTator, text mining | PubMed |
| SERCA Modulators Reveal Distinct Signaling and Functional Roles of T Lymphocyte Ca2+ Stores. | Int J Mol Sci | 2024 | 39596161 | PubTator, text mining | PubMed |
| Structure-preserved integration of scRNA-seq data using heterogeneous graph neural network. | Brief Bioinform | 2024 | 39446194 | PubTator, text mining | PubMed |
| Another-regulin regulates cardiomyocyte calcium handling via integration of neuroendocrine signaling with SERCA2a activity. | J Mol Cell Cardiol | 2024 | 39437886 | PubTator, text mining | PubMed |
| Thapsigargin: a promising natural product with diverse medicinal potential - a review of synthetic approaches and total syntheses. | Org Biomol Chem | 2024 | 39363839 | PubTator, text mining | PubMed |
| Editorial: Current proceedings in magnetocardiology-past, present, future. | Front Cardiovasc Med | 2024 | 39257846 | PubTator, text mining | PubMed |
| Spaceflight increases sarcoplasmic reticulum Ca2+ leak and this cannot be counteracted with BuOE treatment. | NPJ Microgravity | 2024 | 39030182 | PubTator, text mining | PubMed |
| Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition. | Biochim Biophys Acta Biomembr | 2024 | 38986894 | PubTator, text mining | PubMed |
| Inhibition of ER stress using tauroursodeoxycholic acid rescues obesity-evoked cardiac remodeling and contractile anomalies through regulation of ferroptosis. | Chem Biol Interact | 2024 | 38906502 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/489/papers?page=4